NEW YORK (GenomeWeb News) – Roche today reported a 3 percent increase in full-year revenues for its diagnostics division, to 9.7 billion Swiss francs ($8.4 billion) from 9.4 billion Swiss francs ($8.1 billion) in 2007.

The diagnostics division includes several business areas, including molecular diagnostics, which posted a 2 percent dip in revenues, to 1.1 billion Swiss francs, and applied sciences, which recorded an 11 percent increase in sales, to 765 million Swiss francs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.